Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 6, 2013, Pages 870-876

  Lv, Feng ^a   Yu, Yang ^a   Zhang, Bin ^a   Liang, Dong ^a   Li, Zhao Ming ^b   You, Wei ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

apoptosis; docetaxel; estrogen receptor; human breast cancer cell lines; mild hyperthermia; mitogen activated protein kinase

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; DOCETAXEL; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 70; MULTIDRUG RESISTANCE PROTEIN; TAXOID;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; DRUG EFFECT; GENETICS; HEAT; HUMAN; MCF 7 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL CYCLE; HOT TEMPERATURE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; P-GLYCOPROTEIN; RECEPTORS, ESTROGEN; TAXOIDS;

EID: 84891601845     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1214-8     Document Type: Article

References (24)

1. Vasconcelos A, Medeiros R, Veiga I, et al. Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis. Breast J, 2002,8(4):226-229 (Pubitemid 34810583)
2. Yamada Y, Itoh Y, Aoki S, et al. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium. Cancer Chemother Pharmacol, 2009,64(6):1079-1083
3. Mohamed F, Marchettini P, Stuart OA, et al. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol, 2003,10(4):463-468 (Pubitemid 40486946)
4. Klostergaard J, Leroux ME, Auzenne E, et al. Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells. J Cell Biochem, 2006,98(2):356-369
5. Peer AJ, Grimm MJ, Zynda ER, et al. Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia. Immunol Res, 2010,46(1-3):137-154
6. Rong Y, Mack P. Apoptosis induced by hyperthermia in Dunn osteosarcoma cell line in vitro. Int J Hyperthermia, 2000,16(1):19-27 (Pubitemid 30050258)
7. Saga T, Sakahara H, Nakamoto Y, et al. Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia. Eur J Cancer, 2001,37(11):1429-1434 (Pubitemid 32588757)
8. Sawaji Y, Sato T, Takeuchi A, et al. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumor-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer, 2002,86(10):1597-1603 (Pubitemid 34628114)
9. Kanaya Y, Doihara H, Shiroma K, et al. Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice. Surg Today, 2008,38(10):911-920
10. Robins HI, Longo W. Whole body hyperthermia: simple complexities. Intensive Care Med, 1999,25(9):898-900 (Pubitemid 29452532)
11. Wendtner C, Abdel-Rahman S, Baumert J, et al. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer, 2001,37(13):1609-1616 (Pubitemid 32778605)
12. Hildebrandt B, Drager J, Kerner T, et al. Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study. Int J Hyperthermia, 2004,20(3): 317-333 (Pubitemid 38460997)
13. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol, 2005,23(13):3079-3085 (Pubitemid 46224131)
14. Issels RD, Schlemmer M, Lindner LH. The role of hyperthermia in combined treatment in the management of soft tissue sarcoma. Curr Oncol Rep, 2006,8(4):305-309 (Pubitemid 43970982)
15. Takahashi I, Emi Y, Hasuda S, et al. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery, 2002,131(1 Suppl):S78-S84 (Pubitemid 34118620)
16. Nakano H, Kurihara K, Okamoto M, et al. Heat-induced apoptosis and p53 in cultured mammalian cells. Int J Radiat Biol, 1997,71(5):519-529 (Pubitemid 27229749)
17. Zhu HM, Wang N, Huang X, et al. The effects of hyperthermia on apoptosis in human colonic carcinoma cell line Lovo. Yixue Yanjiusheng Xuebao (Chinese), 2005,18(5):399-401
18. Zhang L, Liu RG, Zhou JP, et al. Hyperthemia-induced apoptosis of mouse HepA cell line. J Huazhong Univ Sci Tech [Health Sci] (Chinese),2002,31(6):621
19. Chen WX, Gu ZY, Li YM, et al. Hyperthemia causes apoptosisin human gastric cancer cell line MKN28. Zhongliu Shiyong Zazhi (Chinese), 2001,16(2):126-128
20. Whyte J, Bergin O, Bianchi A, et al. Key signaling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signaling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res, 2009,11(5):209
21. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene, 2003,22(56):9075-9086 (Pubitemid 38121708)
22. Tabuchi Y, Matsuoka J, Gunduz M, et al. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Int J Oncol, 2009,34(2):313-319
23. Vilaboa NE, Galan A, Troyano A, et al. Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1). J Biol Chem, 2000,275(32):24 970-24 976 (Pubitemid 30626605)
24. Kim SH, Yeo GS, Lim YS, et al. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp Mol Med, 1998,30(2):87-92